Silence Therapeutics Plc (SLN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SLN.LN | ||||
| Company | Silence Therapeutics Plc | ||||
| Price Information | |||||
| Exchange | LSE | ||||
| Open | 541.000 | ||||
| High | 546.000 | ||||
| Low | 512.000 | ||||
| Latest | 535.000 | ||||
| Change | -5.000 | ||||
| % Change | -0.93% | ||||
| Volume | 913,528 | ||||
| 20-Day Average Volume | 235,906 | ||||
| Previous Close | 540.000 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 547.400 | ||||
| 20-Day Raw Stochastic | 51.76% | ||||
| 20-Day Relative Strength | 48.25 | ||||
| Weighted Alpha | +8.90 | ||||
| Today's Opinion | 56% Sell | ||||
| Previous Opinion | 56% Sell | ||||
| Last Month's Opinion | 100% Sell | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.65% since 11/22/21 | ||||
| Low | 512.000 on 11/29/21 | ||||
| High | 556.000 on 11/23/21 | ||||
| 1-Month | |||||
| %Chg | +5.94% since 10/29/21 | ||||
| Low | 442.720 on 11/02/21 | ||||
| High | 621.000 on 11/18/21 | ||||
| 3-Month | |||||
| %Chg | -9.17% since 08/27/21 | ||||
| Low | 442.720 on 11/02/21 | ||||
| High | 621.000 on 11/18/21 | ||||
| 6-Month | |||||
| %Chg | -16.41% since 05/28/21 | ||||
| Low | 442.720 on 11/02/21 | ||||
| High | 680.000 on 06/01/21 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 480,348 | ||||
| Shares Outstanding, K | 89,785 | ||||
| Annual Sales | 43,258,000 | ||||
| Annual Net Income | -45,309,000 | ||||
| Last Quarter Sales | 159,000 | ||||
| Last Quarter Net Income | -20,958,000 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||